|

Is the UK the new sick man of Europe?

UK growth was actually weaker than expected last quarter, rising by a mere 0.2% on a quarterly basis, down from 0.3%. This drags the annual rate down to 2% from 2.1%. The UK is now beginning to look like the sick man of Europe with strong GDP figures for Q1 from Spain this morning, where GDP rose 0.8% on the quarter and 3% on an annualised basis, overall Eurozone growth expanded by a 0.5% rate over the first three months’ of the year.

Trade weighs down UK growth figure

Weakness in UK growth was mostly centred in trade, exports were downwardly revised to -1.6%, from 0.5% initially, while imports surged by 2.7%. This suggests that the rebalancing away from the consumer is not happening, and the UK’s exporters have not been able to capitalise on the massive 20% devaluation in sterling last year. If the export industry can’t benefit from such a large currency boon, then the sector looks fairly doomed to me.

Some green shoots for business investment

But it wasn’t all bad news. On the bright side, there were some important upward revisions to the GDP report, notably the pick-up in business investment, which jumped by 0.6% in the first quarter after falling 0.9% in the last three months of 2016. Capital spending also rose by 1.2%, which was also revised higher from -0.2% initially. Private consumption was unrevised at 0.3%, and the index of services was revised higher to 0.2% from flat.
This could be a warning sign for Theresa May. If she can’t get a good Brexit deal that protects UK businesses then the UK economy could suffer as other sectors’ of our economy, like exporters and manufacturers, are not strong enough yet to pick up the slack and drive UK growth.

So, is the UK the sick man of Europe? This growth data isn’t encouraging at the early stage of the Brexit negotiations, however, the fact that the US suffered the same fate and is expected to bounce back later this year is also encouraging and the UK data may follow suit. Added to that, UK corporate earnings for Q1 were strong and beat expectations, thus, if the hard data can follow the corporate data higher then we the weakness in the first quarter GDP could be seen as a slip. At this stage it is too early to call the UK the sick man of Europe, however, another quarter of weak numbers could justify this title.

Why this may not derail GBP/USD on its way above 1.30

The market reaction to this report was muted. A second reading of UK GDP doesn’t tend to set the markets alight. The FTSE is mostly flat on the day, there is hesitancy ahead of the Opec meeting later today, and European stocks are not following the US market higher, the S&P 500 made another record close on Wednesday.

The pound is hovering around the 1.30 level, although it backed off highs at 1.3015 ahead of the report. We continue to think that the pound could creep higher, after the market slashed their short bets on the pound for yet another week last week. There could also be further upside after momentum indicators backed away from overbought levels, suggesting that there could be room for further sterling upside from a technical perspective.

Author

Kathleen Brooks

Kathleen has nearly 15 years’ experience working with some of the leading retail trading and investment companies in the City of London.

More from Kathleen Brooks
Share:

Editor's Picks

EUR/USD: Bears retain control below 1.1780-1.1770 confluence breakpoint

The EUR/USD pair remains on the back foot through the Asian session on Friday and currently trades just above mid-1.1700s, well within striking distance of a nearly one-month low set the previous day.

GBP/USD seems vulnerable near one-month low vs. USD as traders await US data

The GBP/USD pair prolongs its weekly downtrend for the fifth consecutive day on Friday and slides back closer to a nearly one-month low, touched the previous day. Spot prices trade below mid-1.3400s during the Asian session on Friday and seem vulnerable to slide further as traders now look to important US macro data for a fresh impetus.

Gold eyes next breakout on US GDP, PCE inflation data

Gold sticks to recent gains around the $5,000-mark early Friday, biding time before the high-impact US macro events. The focus is now on the US fourth-quarter Gross Domestic Product, core Personal Consumption Expenditures Price Index and the Supreme Court’s ruling on President Donald Trump’s tariffs.

Bitcoin, Ethereum and Ripple remain range-bound as breakdown risks rise

Bitcoin, Ethereum, and Ripple are trading sideways within consolidation ranges on Friday, signaling a lack of directional bias in the broader crypto market. BTC rebounded from key support, and ETH is nearing the lower consolidation boundary, while XRP is holding at its lower trendline boundary. 

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.